Neostigmine is a cholinesterase inhibitor commonly used in the management of myasthenia gravis, postoperative urinary retention, and to reverse the effects of non-depolarizing muscle relaxants after surgery. It works by blocking the breakdown of acetylcholine, thereby enhancing neuromuscular transmission. Ensuring the pharmaceutical purity of Neostigmine is essential for maintaining its safety, efficacy, and compliance with regulatory standards. Impurity profiling aids in detecting and controlling unwanted substances that may arise during synthesis, storage, or degradation. Here are some of its known impurities listed below.
Showing 1 - 4 of 4 products

Catalogue No : NEOS-OCL-001
CAS No : 114-80-7
In Stock
Synonyms
3-[(Dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium bromide
3-[(Dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium bromide

Catalogue No : NEOS-OCL-002
CAS No : 2498-27-3
In Stock
Synonyms
3-Hydroxy-N,N,N-trimethylanilinium Iodide
3-Hydroxy-N,N,N-trimethylanilinium Iodide

Catalogue No : NEOS-OCL-003
CAS No : 99-07-0
In Stock
Synonyms
3-(Dimethylamino)phenol
3-(Dimethylamino)phenol

Catalogue No : NEOS-OCL-004
CAS No : 16088-19-0
In Stock
Synonyms
N-Desmethyl Neostigmine Nor Neostigmine 3-(Dimethylamino)phenyl dimethylcarbamate
N-Desmethyl Neostigmine Nor Neostigmine 3-(Dimethylamino)phenyl dimethylcarbamate